Patents by Inventor Ann Huletsky

Ann Huletsky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11834720
    Abstract: Described herein are novel SCCmec right extremity junction (MREJ) sequences for the detection and/or identification of methicillin-resistant Staphylococcus aureus (MRSA). Disclosed are methods and compositions based on DNA sequences for the specific detection of MREJ sequences designated types xi, xii, xiii, xiv, xv, xvi, xvii, xviii, xix, and xx for diagnostic purposes and/or epidemiological typing.
    Type: Grant
    Filed: October 10, 2006
    Date of Patent: December 5, 2023
    Assignee: GENEOHM SCIENCES, INC.
    Inventors: Ann Huletsky, Richard Giroux
  • Publication number: 20210230672
    Abstract: The present invention describes novel SCCmec right extremity junction sequences for the detection of methicillin-resistant Staphylococcus aureus (MRSA). It relates to the use of these DNA sequences for diagnostic purposes.
    Type: Application
    Filed: October 9, 2020
    Publication date: July 29, 2021
    Inventors: Ann Huletsky, Valery Rossbach
  • Patent number: 10801074
    Abstract: The present invention describes novel SCCmec right extremity junction sequences for the detection of methicillin-resistant Staphyloccocus aureus (MRSA). It relates to the use of these DNA sequences for diagnostic purposes.
    Type: Grant
    Filed: September 11, 2019
    Date of Patent: October 13, 2020
    Assignee: GeneOhm Sciences Canada, Inc.
    Inventors: Ann Huletsky, Valery Rossbach
  • Publication number: 20200109442
    Abstract: The present invention describes novel SCCmec right extremity junction sequences for the detection of methicillin-resistant Staphyloccocus aureus (MRSA). It relates to the use of these DNA sequences for diagnostic purposes.
    Type: Application
    Filed: September 11, 2019
    Publication date: April 9, 2020
    Inventors: Ann Huletsky, Valery Rossbach
  • Patent number: 10577664
    Abstract: The present invention describes novel SCCmec right extremity junction sequences for the detection of methicillin-resistant Staphyloccocus aureus (MRSA). It relates to the use of these DNA sequences for diagnostic purposes.
    Type: Grant
    Filed: September 18, 2017
    Date of Patent: March 3, 2020
    Assignee: GeneOhm Sciences Canada, Inc.
    Inventors: Ann Huletsky, Valery Rossbach
  • Patent number: 10047404
    Abstract: Provided herein are compositions and methods for the detection of Streptococcus agalacticae.
    Type: Grant
    Filed: October 15, 2014
    Date of Patent: August 14, 2018
    Assignee: GENEOHM SCIENCES CANADA, INC.
    Inventors: Michel G. Bergeron, Maurice Boissinot, Ann Huletsky, Christian Menard, Marc Ouellette, Francois J. Picard, Paul H. Roy
  • Publication number: 20180208972
    Abstract: The present invention describes novel SCCmec right extremity junction sequences for the detection of methicillin-resistant Staphyloccocus aureus (MRSA). It relates to the use of these DNA sequences for diagnostic purposes.
    Type: Application
    Filed: September 18, 2017
    Publication date: July 26, 2018
    Inventors: Ann Huletsky, Valery Rossbach
  • Patent number: 9777335
    Abstract: The present invention describes novel SCCmec right extremity junction sequences for the detection of methicillin-resistant Staphyloccocus aureus (MRSA). It relates to the use of these DNA sequences for diagnostic purposes.
    Type: Grant
    Filed: May 2, 2006
    Date of Patent: October 3, 2017
    Assignee: GeneOhm Sciences Canada Inc.
    Inventors: Ann Huletsky, Valery Rossbach
  • Publication number: 20150111760
    Abstract: Provided herein are compositions and methods for the detection of Streptococcus agalacticae.
    Type: Application
    Filed: October 15, 2014
    Publication date: April 23, 2015
    Inventors: Michel G. Bergeron, Maurice Boissinot, Ann Huletsky, Christian Menard, Marc Ouellette, Francois J. Picard, Paul H. Roy
  • Publication number: 20140127684
    Abstract: Provided herein are compositions and methods for the detection of Streptococcus agalacticae.
    Type: Application
    Filed: April 22, 2013
    Publication date: May 8, 2014
    Applicant: GENEOHM SCIENCES CANADA, INC.
    Inventors: Michel G. Bergeron, Maurice Boissinot, Ann Huletsky, Christian Menard, Marc Ouellette, Francois J. Picard, Paul H. Roy
  • Patent number: 8481265
    Abstract: The present invention relates to a method for isolating microorganisms and/or microorganisms nucleic acids from a bodily fluid that may comprise or may be suspected to comprise microorganisms and/or host cells and/or host cells debris. Microorganisms nucleic acids may further be isolated by lysing the isolated microorganisms. The present invention also relates to a method for detecting microorganisms in a bodily fluid. The present invention further relates to a saponin formulation and its use.
    Type: Grant
    Filed: August 1, 2008
    Date of Patent: July 9, 2013
    Assignee: Universite Laval
    Inventors: Régis Peytavi, Ann Huletsky, Lucile Belley-Montfort, Isabelle Martineau
  • Patent number: 8426137
    Abstract: Compositions and methods for the detection of vancomycin-resistant pathogens using primers and/or probes to the vanA and vanB genes.
    Type: Grant
    Filed: July 5, 2011
    Date of Patent: April 23, 2013
    Assignee: Genohm Sciences Canada, Inc.
    Inventors: Michel G. Bergeron, Maurice Boissinot, Ann Huletsky, Christian Menard, Marc Ouellette, Francois J. Picard, Paul H. Roy
  • Patent number: 8182996
    Abstract: Four highly conserved genes, encoding translation elongation factor Tu, translation elongation factor G, the catalytic subunit of proton-translocating ATPase and the RecA recombinase, are used to generate species-specific, genus-specific, family-specific, group-specific and universal nucleic acid probes and amplification primers to rapidly detect and identify algal, archaeal, bacterial, fungal and parasitical pathogens from clinical specimens for diagnosis. The detection of associated antimicrobial agents resistance and toxin genes are also under the scope of the present invention.
    Type: Grant
    Filed: August 21, 2007
    Date of Patent: May 22, 2012
    Assignee: Geneohm Sciences Canada Inc.
    Inventors: Michel G. Bergeron, Maurice Boissinot, Ann Huletsky, Christian Ménard, Marc Ouellette, François J. Picard, Paul H. Roy
  • Publication number: 20120058487
    Abstract: Four highly conserved genes, encoding translation elongation factor Tu, translation elongation factor G, the catalytic subunit of proton-translocating ATPase and the RecA recombinase, are used to generate species-specific, genus-specific, family-specific, group-specific and universal nucleic acid probes and amplification primers to rapidly detect and identify algal, archaeal, bacterial, fungal and parasitical pathogens from clinical specimens for diagnosis. The detection of associated antimicrobial agents resistance and toxin genes are also under the scope of the present invention.
    Type: Application
    Filed: August 21, 2007
    Publication date: March 8, 2012
    Inventors: Michel G. Bergeron, Maurice Boissinot, Ann Huletsky, Christian Menard, Marc Ouellette, Francois J. Picard, Paul H. Roy
  • Patent number: 8114601
    Abstract: Four highly conserved genes, encoding translation elongation factor Tu, translation elongation factor G, the catalytic subunit of proton-translocating ATPase and the RecA recombinase, are used to generate species-specific, genus-specific, family-specific, group-specific and universal nucleic acid probes and amplification primers to rapidly detect and identify algal, archaeal, bacterial, fungal and parasitical pathogens from clinical specimens for diagnosis. The detection of associated antimicrobial agents resistance and toxin genes are also under the scope of the present invention.
    Type: Grant
    Filed: September 27, 2005
    Date of Patent: February 14, 2012
    Assignee: GeneOhm Sciences Canada Inc.
    Inventors: Michel G. Bergeron, Maurice Boissinot, Ann Huletsky, Christian Ménard, Marc Ouellette, François J. Picard, Paul H. Roy
  • Publication number: 20120035071
    Abstract: Compositions and methods for the detection of vancomycin-resistant pathogens using primers and/or probes to the vanA and vanB genes.
    Type: Application
    Filed: July 5, 2011
    Publication date: February 9, 2012
    Applicant: GENEOHM SCIENCES CANADA, INC.
    Inventors: MICHEL G. BERGERON, MAURICE BOISSINOT, ANN HULETSKY, CHRISTIAN MENARD, MARC OUELLETTE, FRANCOIS PICARD, PAUL H. ROY
  • Publication number: 20110294128
    Abstract: The present invention relates to a method for isolating microorganisms and/or microorganisms nucleic acids from a bodily fluid that may comprise or may be suspected to comprise microorganisms and/or host cells and/or host cells debris. Microorganisms nucleic acids may further be isolated by lysing the isolated microorganisms. The present invention also relates to a method for detecting microorganisms in a bodily fluid. The present invention further relates to a saponin formulation and its use.
    Type: Application
    Filed: August 1, 2008
    Publication date: December 1, 2011
    Applicant: Universite Laval
    Inventors: Régis Peytavi, Ann Huletsky, Lucile Belley-Montfort, Isabelle Martineau
  • Patent number: 7838221
    Abstract: Described herein are novel SCCmec right extremity junction (MREJ) sequences for the detection and/or identification of methicillin-resistant Staphylococcus aureus (MRSA). Disclosed are methods and compositions based on DNA sequences for the specific detection of MREJ sequences designated types xi, xii, xiii, xiv, xv, xvi, xvii, xviii, xix, and xx for diagnostic purposes and/or epidemiological typing.
    Type: Grant
    Filed: October 11, 2005
    Date of Patent: November 23, 2010
    Assignee: Geneohm Sciences, Inc.
    Inventors: Ann Huletsky, Richard Giroux
  • Publication number: 20100267012
    Abstract: Compositions and methods for the detection of vancomycin-resistant pathogens using primers and/or probes to the vanA and vanB genes.
    Type: Application
    Filed: September 14, 2006
    Publication date: October 21, 2010
    Inventors: Michel G. Bergeron, Maurice Boissinot, Ann Huletsky, Christian Menard, Marc Ouellette, Francois Picard, Paul H. Roy
  • Publication number: 20090068641
    Abstract: Four highly conserved genes, encoding translation elongation factor Tu, translation elongation factor G, the catalytic subunit of proton-translocating ATPase and the RecA recombinase, are used to generate species-specific, genus-specific, family-specific, group-specific and universal nucleic acid probes and amplification primers to rapidly detect and identify algal, archaeal, bacterial, fungal and parasitical pathogens from clinical specimens for diagnosis. The detection of associated antimicrobial agents resistance and toxin genes are also under the scope of the present invention.
    Type: Application
    Filed: September 27, 2005
    Publication date: March 12, 2009
    Inventors: Michel G. Bergeron, Maurice Boissinot, Ann Huletsky, Christian Menard, Marc Ouellette, Francois J. Picard, Paul H. Roy